Kopran Ltd Share Price

₹130.90 0.60 (0.46%) BSE
as updated on 12-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:129.50
  • Day's High:131.60

  • 52 Week Low123.75
  • 52 Week High227.10

Kopran Ltd's key Fundamentals

Market Cap ₹632 Cr.
P/E Ratio 40.7
TTM EPS 3.2
P/B Ratio 1.52
ROE 5.88
Debt to Equity 0.11
Face Value 10
BVPS 86.2
3 Year Sales Growth 9.84%

Kopran Ltd's Share Price Returns

1 Day 0.46%
1 Week -3.50%
1 Month -8.10%
3 Months -25.00%
6 Months -31.20%
1 Years -38.50%
3 Years -16.40%
5 Years -1.30%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Kopran Ltd Shareholding Pattern

Promoters

(44.42%)

Institutions

(0.60%)

Non-Institutions

(54.98%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Kopran Ltd

The company was incorporated on April 26, 1958 as a private limited company under the name Kopran Chemical Company Pvt. Ltd. by Ramanlal V Shah Sevantilal, A Shah , Chimanlal G Sheth and Jivanalal M Shah. In 1972, the company’s management was acquired by Chemo Pharma Laboratories Ltd and the Company’s products were marketed by them.

Promoted by the Parijat Enterprises, Kopran is currently an integrated health care company. Kopran has used research-based technology to contribute towards total health-care. The company started modestly as a Semi Synthetic Penicillin (SSP) player and expanded to becomes the largest SSP Player in India with an annual SSP facility of over 1200 tones per annum.Subsequently the SSP business was hived off into a separate Company in a joint venture with Synpac Pharmaceuticals Ltd, UK.Kopran Laboratories Ltd. markets and supports high-tech life-saving medical equipments and diagnostics reagents since 1988.

Kopran Research Laboratories Ltd. (KRLL) is an emerging research organisation with particular interests in the areas of drug discovery, polymer technology and synthesis of new molecules.

Kopran is working towards creating and maintaining a global presence.Presence in Africa through Kampala Pharmaceutical Industries (KPI),a pharmaceutical company engaged in the manufacture and marketing of finished dosage forms in Uganda.

The company is having presence in the Middle East Market through a joint venture with Dubai Investment Corporation a leading investment company in Dubai for the manufacture and marketing of finished dosage forms in Dubai.

KRLL is a 100% subsidiary of Kopran Ltd.  KRLL is recognised by the Department of Science and Industrial Research (DSIR), Government of India. The company is staffed with competent and dedicated team of scientists.

Product range of the company includes:

Finished Dosage Forms

  • Antibiotics/antibacterials
  • Anti-malarial
  • Cadiovasculars
  • Pain management
  • Anthelminthics
  • Antiprotozoals
  • Antidiabetics
  • Gastrointestinals
  • Drug for erectile dysfuntion
  • Antiallergics
  • Respiratory/anti-asthmatics
  • Metered dose inhalers
  • Dry powder inhalers
  • Antiviral

Active Pharmaceutical Ingredients

  • Anti-hypertensives
  • Macrolides
  • Taste Masked
  • Cephalosporins 
  • Under Development
  • Others

Achievements/ recognition:

  • Kopran has a state of art manufacturing plants (Penicillin & General) approved by: -MCC (South Africa) -TGA, Australia and FDA, USA are in the pipeline

Future plans:

  • Brand Equity Development
  • Research for New Chemical Entities
  • Globalise its operations thus making Kopran a truly International Pharmaceutical Company.
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 129.50
  • Day's High: 131.60

  • 52 Week Low123.75
  • 52 Week High227.10

Kopran Ltd's key Fundamentals

Market Cap ₹632 Cr.
P/E Ratio 40.7
TTM EPS 3.2
P/B Ratio 1.52
ROE 5.88
Debt to Equity 0.11
Face Value 10
BVPS 86.2
3 Year Sales Growth 9.84%

Kopran Ltd's Share Price Returns

1 Day 0.46%
1 Week -3.50%
1 Month -8.10%
3 Months -25.00%
6 Months -31.20%
1 Years -38.50%
3 Years -16.40%
5 Years -1.30%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×